- Syringin
-
- $45.00 / 5mg
-
2024-11-19
- CAS:118-34-3
- Min. Order:
- Purity: 99.56%
- Supply Ability: 10g
- Syringin
-
- $0.00 / 20mg
-
2023-02-24
- CAS:118-34-3
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
- ELEUTHEROSIDE B
-
- $29.00 / 100KG
-
2019-07-06
- CAS:118-34-3
- Min. Order: 25KG
- Purity: 99%
- Supply Ability: 10000kg
|
| | ELEUTHEROSIDE B Basic information |
| | ELEUTHEROSIDE B Chemical Properties |
| Melting point | 192°C | | Boiling point | 421.84°C (rough estimate) | | density | 1.2870 (rough estimate) | | refractive index | 1.6230 (estimate) | | storage temp. | Sealed in dry,2-8°C | | solubility | DMSO (Slightly), Methanol (Slightly, Sonicated), Water (Slightly) | | form | Solid | | pka | 12.75±0.70(Predicted) | | color | White to Off-White | | BRN | 97166 | | InChIKey | QJVXKWHHAMZTBY-GCPOEHJPSA-N | | LogP | -1.550 (est) | | CAS DataBase Reference | 118-34-3 | | EPA Substance Registry System | Syringin (118-34-3) |
| Safety Statements | 24/25 | | WGK Germany | 3 | | HS Code | 29329990 |
| | ELEUTHEROSIDE B Usage And Synthesis |
| Description | Syringin is a phenylpropanoid glycoside first isolated from A. senticosus that enhances acetylcholine release in pancreatic cells leading to an increase in insulin release through the muscarinic M3 receptor. Syringin dose-dependently (50, 75, and 100 μg/kg, i.v.) decreases plasma glucose levels and increases insulin-like immunoreactivity and C-peptide in rats, and these effects last at least 60 minutes. In a rat model of type 1 diabetes, it decreases plasma glucose and increases β-endorphin release from the adrenal medulla. Syringin increases autophagy through AMP-activated protein kinase α (AMPKα) activation concomitant with preventing the progression of cardiac hypertrophy in mice following aortic banding. It also has immunomodulatory effects, likely due to its metabolite sinapyl alcohol. | | Chemical Properties | Off-White Solid | | Uses | Syringin is a chemical that is found naturally in various plants such as Araliaceae, a adaptogenic agent with Syringin as the active componet. Syringin have exhibited the ability to enhance glucose utilization and the lowering of plasma glucose level in rats suffering from insulin deficiency, suggesting that this chemical may be useful in the treatment of human diabetes. | | Definition | ChEBI: Syringin is a monosaccharide derivative that is trans-sinapyl alcohol attached to a beta-D-glucopyranosyl residue at position 1 via a glycosidic linkage. It has a role as a hepatoprotective agent and a plant metabolite. It is a beta-D-glucoside, a monosaccharide derivative, a primary alcohol and a dimethoxybenzene. It is functionally related to a trans-sinapyl alcohol. |
| | ELEUTHEROSIDE B Preparation Products And Raw materials |
|